December 20, 2021
Webinar
Experts from Optum, WellMed, and Reliant discuss strategies for bringing value-based payment into specialty care through the use of education and analytics.
September 25, 2021
Article
With the Oncology Care Model (OCM) slated to end in 2022, the successor model is still not in place. According to panelists, there is likely going to be a gap after OCM ends and the new model begins, but more importantly, practices should prepare for the new model to be mandatory.
September 09, 2021
The administration said it would make the results of its drug price negotiations with manufacturers, as well as its approach to value-based care models, open to a variety of payers.
August 10, 2021
In segment 5, the panelists discuss the impact of COVID-19 and future considerations for clinical research.
In segment 4, the panelists discuss regulatory considerations for real-world evidence and real-world data.
In segment 3, the panelists discuss the impacts of real-world evidence and real-world data on drug evaluation.
